CARIS LIFE SCIENCES, INC. (CAI) /
The cash flow of CARIS LIFE SCIENCES, INC. over the past 3 years
Chart CARIS LIFE SCIENCES, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2023–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, CARIS LIFE SCIENCES, INC.'s operating cash flow was $83.16M and its capital expenditures $16.26M, leaving free cash flow of $66.89M. Free cash flow was above zero in 1 of the 3 years shown. It ranged from -$298.42M in fiscal 2023 to $66.89M in fiscal 2025. Capital expenditures were highest in fiscal 2023, at $22.32M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $83.16M | $16.26M | $66.89M |
| 2024ended Dec 31, 2024 | -$245.2M | $8.44M | -$253.64M |
| 2023ended Dec 31, 2023 | -$276.1M | $22.32M | -$298.42M |
Fiscal years as CARIS LIFE SCIENCES, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on CARIS LIFE SCIENCES, INC.
- The revenue of CARIS LIFE SCIENCES, INC.
- The profitability of CARIS LIFE SCIENCES, INC.
- All of CARIS LIFE SCIENCES, INC.'s financials, charted
Companies of a similar size
- PNRPentair plc
- APTVAPTIV PLC
- VNOMViper Energy, Inc.
- DARDARLING INGREDIENTS INC.
- JXNJackson Financial Inc.
Not investment advice. This page shows what CARIS LIFE SCIENCES, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.